NECTAR LIFESCIENCES
Back to Income Statement
|
NECTAR LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-114 Cr | ₹5.00 Cr | ₹-24 Cr | ₹25 Cr | ₹-73 Cr |
What is the latest Consolidated Net Profit of NECTAR LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-114 Cr |
| Mar2025 | ₹5.00 Cr |
| Mar2024 | ₹-24 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹-73 Cr |
How is Consolidated Net Profit of NECTAR LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-114 Cr | Negative | |
| Mar2025 | ₹5.00 Cr | Positive | |
| Mar2024 | ₹-24 Cr | Negative | |
| Mar2023 | ₹25 Cr | Positive | |
| Mar2022 | ₹-73 Cr | - | |
Compare Consolidated Net Profit of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹195.3 Cr | -0.8% | -11.7% | -28.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -0.8% |
-11.7% |
-28.1% |
| SENSEX | 3.8% |
-0.6% |
-9.1% |
You may also like the below Video Courses